The Role of Niacin in Lipid-lowering Treatment: Are we Aiming Too High?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|17|3094-3106

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.17, 2013-05, pp. : 3094-3106

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Lipid-Lowering Pharmacotherapy in Children

By Tonstad S.  

Pediatric Drugs, Vol. 2, Iss. 1, 2000-01 ,pp. : 11-22

Adis International

Access to resources Recommend Favorite

Outcomes of Lipid-Lowering Treatment in Postmenopausal Women

By LaRosa J.C.  

Drugs & Aging, Vol. 19, Iss. 8, 2002-01 ,pp. : 595-604

Adis International

Access to resources Recommend Favorite

Multiple Lipid-lowering Treatment in Pediatric Patients with Hyperlipidemia

By  

Medicinal Chemistry, Vol. 8, Iss. 6, 2012-11 ,pp. : 1171-1181

Bentham Science Publishers

Access to resources Recommend Favorite

Hyperlipidaemia in Paediatric Patients: The Role of Lipid-Lowering Therapy in Clinical Practice

By Wierzbicki Anthony S.  

Drug Safety, Vol. 33, Iss. 2, 2010-02 ,pp. : 115-125

Adis International

Access to resources Recommend Favorite

Preventing Cardiovascular Outcome in Patients with Renal Impairment: Is There a Role for Lipid-Lowering Therapy?

By Holdaas Hallvard  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 4, 2005-01 ,pp. : 255-269

Adis International

Access to resources Recommend Favorite